A detailed history of Jefferies Financial Group Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Jefferies Financial Group Inc. holds 5,449 shares of CRL stock, worth $995,205. This represents 0.01% of its overall portfolio holdings.

Number of Shares
5,449
Holding current value
$995,205
% of portfolio
0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$187.96 - $245.29 $1.02 Million - $1.34 Million
5,449 New
5,449 $1.07 Million
Q1 2024

May 13, 2024

BUY
$203.52 - $273.43 $1.77 Million - $2.38 Million
8,720 New
8,720 $2.36 Million
Q3 2023

Nov 14, 2023

BUY
$194.44 - $217.61 $233,133 - $260,914
1,199 New
1,199 $234,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.29B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Jefferies Financial Group Inc. Portfolio

Follow Jefferies Financial Group Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Financial Group Inc., based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Financial Group Inc. with notifications on news.